https://ijrps.com/index.php/home/issue/feed International Journal of Research in Pharmaceutical Sciences 2023-02-01T04:42:51+00:00 Editor ijrpseditor@gmail.com Open Journal Systems <p align="justify">International Journal of Research in Pharmaceutical Sciences (IJRPS) ISSN: 0975-7538 sponsored by JK Welfare &amp; Pharmascope Foundation is established in the year 2009 with people from various avenues of the pharmacy profession. IJRPS is completely devoted to publications related to Pharmaceuticals and Health Sciences. IJRPS will be published quarterly. The journal publishes original research work that contributes significantly to further the scientific knowledge in Pharmaceutical and Health Sciences.</p> https://ijrps.com/index.php/home/article/view/4174 Test 2023-01-05T04:35:33+00:00 Neelam Injeti neels.injeti@gmail.com <p>check</p> 2023-01-05T00:00:00+00:00 Copyright (c) 2023 https://ijrps.com/index.php/home/article/view/4175 Madhuca longifolia leaf extract mediated synthesis of ZnO nanoparticles and their Antibacterial, Antioxidant, and Photocatalytic activity 2023-01-05T04:36:40+00:00 Rajani Rajaniyadav9083@gmail.com Rishi Kesh Meena Rajaniyadav9083@gmail.com Preeti Mishra Rajaniyadav9083@gmail.com <p>The biogenic synthesis of ZnO NPs is a promising substitute for the standard method of NP synthesis. In the current study, ZnO nanoparticles were produced biologically. Leaf extract from the <em>Madhuca longifolia</em> (M-ZnO NPs) plant was used to create ZnO NPs, which were then examined using UV-vis, XRD, FTIR, SEM, and TEM. SEM and TEM examination and XRD validated the size and crystalline nature of Zinc oxide nanoparticles, respectively. Functional groups involved in the production of ZnO NPs were visible in the FTIR spectra. By scavenging DPPH free radicals at various concentrations, the antioxidant activity of green ZnO NPs was determined. By using the agar well diffusion method, ZnO NPs were tested for their bactericidal potential against Gram-negative bacteria <em>E. coli</em> and Gram-positive bacteria <em>Staphylococcus aureus</em> bacterial strains. A 96% photodegradation of MB dye and 91% degradation of textile wastewater was observed in green-produced ZnO NPs when exposed to sunshine. The recent work proved that ZnO NPs have substantial antioxidant, antibacterial, and photocatalytic activity. Therefore, the study offers a straightforward, practical, economical, and ecologically secure green synthesis technique for the biofabrication of multifunctional ZnO nanoparticles.</p> 2023-01-05T00:00:00+00:00 Copyright (c) 2023 International Journal of Research in Pharmaceutical Sciences https://ijrps.com/index.php/home/article/view/4176 Development and Validation of a simple UV spectrophotometric method for the determination of Delamanid 2023-01-05T05:45:44+00:00 Vaishali Pardeshi vaishali.pardeshi12@gmail.com Tushar Lokhande vaishali.pardeshi12@gmail.com Rina Firke vaishali.pardeshi12@gmail.com Sneha Patil vaishali.pardeshi12@gmail.com Vishakha Pawar vaishali.pardeshi12@gmail.com <p>Using a Shimadzu UV-2600, a quick, precise, easy, and affordable UV spectrophotometric approach has been created. Solvent made with methanol to assess the bulk Delamanid content. A wavelength of 320 nm was used for the detection process. The parameters linearity, accuracy, precision, ruggedness, robustness, LOD, and LOQ were taken into consideration during method validation in accordance with ICH Q2R1 criteria. It demonstrated linearity in the range of 60-360 (/mL) at a predetermined λmax of 320 nm, and it had a strong correlation coefficient (R2-0.996) and outstanding mean recovery (99.00-100.07%). Determination of Delamanid used this technique effectively. The method's linearity, accuracy, repeatability, and reproducibility were statistically and by recovery experiments confirmed. The outcomes demonstrated the method's applicability for both regular Delamanid bulk analysis and commercial formulations.</p> 2023-01-05T00:00:00+00:00 Copyright (c) 2023 https://ijrps.com/index.php/home/article/view/4208 Etiological Evaluation of Microcytic Hypochromic Anemia at a Tertiary Care Hospital in the Eastern Part of India 2023-02-01T04:42:51+00:00 Prabhat Kumar drlalitmeena@gmail.com Arun Kumar Singh drlalitmeena@gmail.com Anju Bharti drlalitmeena@gmail.com Sandeep Kumar drlalitmeena@gmail.com Chanda Hemaliya drlalitmeena@gmail.com Sandip Kumar drlalitmeena@gmail.com Lalit Prashant Meena drlalitmeena@gmail.com <p>Microcytic hypochromic anemia is a part anemia classification based on the morphology of anemia with well-known causes and management. The causes of microcytic hypochromic anemia may be either due to iron deficiency anemia, anemia of inflammation, or thalassemia. There are lots of recent advancements and studies done on the etiology of Microcytic Hypochromic anemia but accurate data especially from the eastern part of India are notavailable. To investigate the causes of Microcytic Hypochromic anaemia at a tertiary care centre in eastern India. After obtaining valid written consent, cases of microcytic hypochromic anaemia were selected from the OPD and indoors for this cross-sectional investigation. The whole haematological and biochemical investigations were sent for anaemia workup. The study comprised 100 patients with microcytic hypochromic disorder. The study comprised subjects ranging in age from 18 to 80 years. 39% were men and 61% were women. In thalassemia patients, the most common were b-thalassemia traits in 81.8 %, followed by 9% of each Delta B–thalassemia and double heterozygous HBE and beta thalassemia. Anemia is not an illness in and of itself, but rather a symptom of another, hence finding the underlying cause is significantly more important. The diagnosis of microcytic hypochromic anaemia is insufficient in the absence of an underlying cause. Special precautions will be made to determine the cause of iron deficient anaemia. The thalassemia trait must also be diagnosed in order to minimise excessive iron supplementation and for family screening.</p> 2023-02-01T00:00:00+00:00 Copyright (c) 2023 https://ijrps.com/index.php/home/article/view/4177 Diagnostic Aids and Techniques of Oral Cancer- An Updated Review 2023-01-05T06:49:38+00:00 Deivanayagi M i.afreenfathima@gmail.com Afreen Fathima I i.afreenfathima@gmail.com <p>Oral cancer is the most prevalent and lethal type with a four in every 3000 incidence rate worldwide and a 3% survival rate. Oral squamous cell carcinoma (OSCC), which is multifactorial, is brought on by genetic and epigenetic instability. Oral potentially malignant disorders (OPMDs) are precursor lesions that often precede oral cancer, and their early diagnosis is advantageous for patients since it may lengthen their productive longevity. Currently, oral cancer screening, early identification, and its pre-invasive intraepithelial phases are still largely focused on visual inspection of the mouth. These methods are subjective and early lesions can be easily missed. Due to a lack of early identification, oral cancer's five-year survival rate is still low. Recently, the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) emphasised that by developing efficient cancer control and screening strategies, we can prevent a third of the 15 million cancer cases that are expected to occur in the future and better manage a second third. Oral cancer screening aids and techniques have witnessed a lot of advancements recently. This article reviews the current diagnostic methods and instruments for detecting oral cancer, which include the oral CDx brush, Velscope, Chemiluminescence, DNA ploidy, microarray technology, colposcopy, and oral scan. It also adds on the molecular (genetic and epigenetic alterations) &amp; decoding of the oral carcinogenesis genomics data.</p> 2023-01-05T00:00:00+00:00 Copyright (c) 2023 https://ijrps.com/index.php/home/article/view/4178 Complete Heart Block with Pacemaker in Pregnancy 2023-01-09T04:48:08+00:00 Rupal Sipani drupals2012@gmail.com Jayarakkini A drupals2012@gmail.com Shanthi E drupals2012@gmail.com <p>Nowadays many women with pacemakers in heart are contemplating and undergoing pregnancy. Complete heart block is an important obstetric complication. Pregnancy with complete heart block is rare and it requires a multidisciplinary approach involving the obstetrician, cardiologist, anaesthesiologist and neonatologist. Though data on such patients where the cardiac association with obstetrics is limited. We present a case of a pregnant woman with congenital complete heart block with permanent pacemaker insitu. 21 year old primigravida at 36 weeks of gestation with congenital complete heart block and pacemaker in situ came to OPD with complaints of pain abdomen. The patient was asymptomatic throughout the pregnancy. The patient was admitted &amp; on evaluation was found to have threatened preterm labour &amp; underwent emergency LSCS &amp; delivered a girl child with a good Apgar score of 8/10,9/10. Intra op &amp; post-op mother &amp; baby was doing good &amp; stable throughout the hospital stay.</p> 2023-01-09T00:00:00+00:00 Copyright (c) 2023